Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Clinical trial NCT02903771 · COMPLETED
Trial details
- NCT number
- NCT02903771
- Sponsor
- Kazia Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2020-03-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.